Global Oncolytic Viral Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Oncolytic Viral Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Oncolytic virus (OV) is a type of virus that can specifically replicate and cause cancer cell apoptosis while sparing normal tissue from being destroyed. Oncolytic virus therapy is a promising cancer treatment method. OVs can be divided into 2 main categories: natural viruses and genetically modified viruses. Naturally occurring OVs include reovirus, Newcastle disease virus (NDV), enterovirus and measles virus (MV), etc., and most OVs have been genetically modified to increase the tropism of the virus to tumor cells and improve virus selection. sexual replication and lytic potential, and enhance host anti-tumor immunity.
The Global Info Research report includes an overview of the development of the Oncolytic Viral Drugs industry chain, the market status of Nasopharyngeal Cancer (Natural Virus, Genetically Modified Virus), Melanoma (Natural Virus, Genetically Modified Virus), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Viral Drugs.
Regionally, the report analyzes the Oncolytic Viral Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Viral Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncolytic Viral Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Viral Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Natural Virus, Genetically Modified Virus).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Viral Drugs market.
Regional Analysis: The report involves examining the Oncolytic Viral Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Viral Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncolytic Viral Drugs:
Company Analysis: Report covers individual Oncolytic Viral Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Viral Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Nasopharyngeal Cancer, Melanoma).
Technology Analysis: Report covers specific technologies relevant to Oncolytic Viral Drugs. It assesses the current state, advancements, and potential future developments in Oncolytic Viral Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Viral Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncolytic Viral Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Oncolytic Viral Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oncolytic Viral Drugs, with price, sales, revenue and global market share of Oncolytic Viral Drugs from 2018 to 2023.
Chapter 3, the Oncolytic Viral Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncolytic Viral Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oncolytic Viral Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oncolytic Viral Drugs.
Chapter 14 and 15, to describe Oncolytic Viral Drugs sales channel, distributors, customers, research findings and conclusion.
Oncolytic virus (OV) is a type of virus that can specifically replicate and cause cancer cell apoptosis while sparing normal tissue from being destroyed. Oncolytic virus therapy is a promising cancer treatment method. OVs can be divided into 2 main categories: natural viruses and genetically modified viruses. Naturally occurring OVs include reovirus, Newcastle disease virus (NDV), enterovirus and measles virus (MV), etc., and most OVs have been genetically modified to increase the tropism of the virus to tumor cells and improve virus selection. sexual replication and lytic potential, and enhance host anti-tumor immunity.
The Global Info Research report includes an overview of the development of the Oncolytic Viral Drugs industry chain, the market status of Nasopharyngeal Cancer (Natural Virus, Genetically Modified Virus), Melanoma (Natural Virus, Genetically Modified Virus), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Viral Drugs.
Regionally, the report analyzes the Oncolytic Viral Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Viral Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncolytic Viral Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Viral Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Natural Virus, Genetically Modified Virus).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Viral Drugs market.
Regional Analysis: The report involves examining the Oncolytic Viral Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Viral Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncolytic Viral Drugs:
Company Analysis: Report covers individual Oncolytic Viral Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Viral Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Nasopharyngeal Cancer, Melanoma).
Technology Analysis: Report covers specific technologies relevant to Oncolytic Viral Drugs. It assesses the current state, advancements, and potential future developments in Oncolytic Viral Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Viral Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncolytic Viral Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Natural Virus
- Genetically Modified Virus
- Nasopharyngeal Cancer
- Melanoma
- Glioma
- Other
- Amgen, Inc.
- Daiichi Sankyo Co., Ltd.
- Rigvir Holding
- Shanghai Pharma Sunway Biotech
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Oncolytic Viral Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oncolytic Viral Drugs, with price, sales, revenue and global market share of Oncolytic Viral Drugs from 2018 to 2023.
Chapter 3, the Oncolytic Viral Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncolytic Viral Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oncolytic Viral Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oncolytic Viral Drugs.
Chapter 14 and 15, to describe Oncolytic Viral Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Oncolytic Viral Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oncolytic Viral Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Natural Virus
1.3.3 Genetically Modified Virus
1.4 Market Analysis by Application
1.4.1 Overview: Global Oncolytic Viral Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Nasopharyngeal Cancer
1.4.3 Melanoma
1.4.4 Glioma
1.4.5 Other
1.5 Global Oncolytic Viral Drugs Market Size & Forecast
1.5.1 Global Oncolytic Viral Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oncolytic Viral Drugs Sales Quantity (2018-2029)
1.5.3 Global Oncolytic Viral Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Amgen, Inc.
2.1.1 Amgen, Inc. Details
2.1.2 Amgen, Inc. Major Business
2.1.3 Amgen, Inc. Oncolytic Viral Drugs Product and Services
2.1.4 Amgen, Inc. Oncolytic Viral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen, Inc. Recent Developments/Updates
2.2 Daiichi Sankyo Co., Ltd.
2.2.1 Daiichi Sankyo Co., Ltd. Details
2.2.2 Daiichi Sankyo Co., Ltd. Major Business
2.2.3 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product and Services
2.2.4 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Daiichi Sankyo Co., Ltd. Recent Developments/Updates
2.3 Rigvir Holding
2.3.1 Rigvir Holding Details
2.3.2 Rigvir Holding Major Business
2.3.3 Rigvir Holding Oncolytic Viral Drugs Product and Services
2.3.4 Rigvir Holding Oncolytic Viral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Rigvir Holding Recent Developments/Updates
2.4 Shanghai Pharma Sunway Biotech
2.4.1 Shanghai Pharma Sunway Biotech Details
2.4.2 Shanghai Pharma Sunway Biotech Major Business
2.4.3 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product and Services
2.4.4 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Pharma Sunway Biotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ONCOLYTIC VIRAL DRUGS BY MANUFACTURER
3.1 Global Oncolytic Viral Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oncolytic Viral Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Oncolytic Viral Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oncolytic Viral Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oncolytic Viral Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Oncolytic Viral Drugs Manufacturer Market Share in 2022
3.5 Oncolytic Viral Drugs Market: Overall Company Footprint Analysis
3.5.1 Oncolytic Viral Drugs Market: Region Footprint
3.5.2 Oncolytic Viral Drugs Market: Company Product Type Footprint
3.5.3 Oncolytic Viral Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oncolytic Viral Drugs Market Size by Region
4.1.1 Global Oncolytic Viral Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Oncolytic Viral Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Oncolytic Viral Drugs Average Price by Region (2018-2029)
4.2 North America Oncolytic Viral Drugs Consumption Value (2018-2029)
4.3 Europe Oncolytic Viral Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Oncolytic Viral Drugs Consumption Value (2018-2029)
4.5 South America Oncolytic Viral Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Oncolytic Viral Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
5.2 Global Oncolytic Viral Drugs Consumption Value by Type (2018-2029)
5.3 Global Oncolytic Viral Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
6.2 Global Oncolytic Viral Drugs Consumption Value by Application (2018-2029)
6.3 Global Oncolytic Viral Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
7.2 North America Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
7.3 North America Oncolytic Viral Drugs Market Size by Country
7.3.1 North America Oncolytic Viral Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Oncolytic Viral Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Oncolytic Viral Drugs Market Size by Country
8.3.1 Europe Oncolytic Viral Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Oncolytic Viral Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oncolytic Viral Drugs Market Size by Region
9.3.1 Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oncolytic Viral Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
10.2 South America Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
10.3 South America Oncolytic Viral Drugs Market Size by Country
10.3.1 South America Oncolytic Viral Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Oncolytic Viral Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oncolytic Viral Drugs Market Size by Country
11.3.1 Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oncolytic Viral Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Oncolytic Viral Drugs Market Drivers
12.2 Oncolytic Viral Drugs Market Restraints
12.3 Oncolytic Viral Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oncolytic Viral Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oncolytic Viral Drugs
13.3 Oncolytic Viral Drugs Production Process
13.4 Oncolytic Viral Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oncolytic Viral Drugs Typical Distributors
14.3 Oncolytic Viral Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Oncolytic Viral Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oncolytic Viral Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Natural Virus
1.3.3 Genetically Modified Virus
1.4 Market Analysis by Application
1.4.1 Overview: Global Oncolytic Viral Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Nasopharyngeal Cancer
1.4.3 Melanoma
1.4.4 Glioma
1.4.5 Other
1.5 Global Oncolytic Viral Drugs Market Size & Forecast
1.5.1 Global Oncolytic Viral Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oncolytic Viral Drugs Sales Quantity (2018-2029)
1.5.3 Global Oncolytic Viral Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Amgen, Inc.
2.1.1 Amgen, Inc. Details
2.1.2 Amgen, Inc. Major Business
2.1.3 Amgen, Inc. Oncolytic Viral Drugs Product and Services
2.1.4 Amgen, Inc. Oncolytic Viral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen, Inc. Recent Developments/Updates
2.2 Daiichi Sankyo Co., Ltd.
2.2.1 Daiichi Sankyo Co., Ltd. Details
2.2.2 Daiichi Sankyo Co., Ltd. Major Business
2.2.3 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product and Services
2.2.4 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Daiichi Sankyo Co., Ltd. Recent Developments/Updates
2.3 Rigvir Holding
2.3.1 Rigvir Holding Details
2.3.2 Rigvir Holding Major Business
2.3.3 Rigvir Holding Oncolytic Viral Drugs Product and Services
2.3.4 Rigvir Holding Oncolytic Viral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Rigvir Holding Recent Developments/Updates
2.4 Shanghai Pharma Sunway Biotech
2.4.1 Shanghai Pharma Sunway Biotech Details
2.4.2 Shanghai Pharma Sunway Biotech Major Business
2.4.3 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product and Services
2.4.4 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Pharma Sunway Biotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ONCOLYTIC VIRAL DRUGS BY MANUFACTURER
3.1 Global Oncolytic Viral Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oncolytic Viral Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Oncolytic Viral Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oncolytic Viral Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oncolytic Viral Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Oncolytic Viral Drugs Manufacturer Market Share in 2022
3.5 Oncolytic Viral Drugs Market: Overall Company Footprint Analysis
3.5.1 Oncolytic Viral Drugs Market: Region Footprint
3.5.2 Oncolytic Viral Drugs Market: Company Product Type Footprint
3.5.3 Oncolytic Viral Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oncolytic Viral Drugs Market Size by Region
4.1.1 Global Oncolytic Viral Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Oncolytic Viral Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Oncolytic Viral Drugs Average Price by Region (2018-2029)
4.2 North America Oncolytic Viral Drugs Consumption Value (2018-2029)
4.3 Europe Oncolytic Viral Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Oncolytic Viral Drugs Consumption Value (2018-2029)
4.5 South America Oncolytic Viral Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Oncolytic Viral Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
5.2 Global Oncolytic Viral Drugs Consumption Value by Type (2018-2029)
5.3 Global Oncolytic Viral Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
6.2 Global Oncolytic Viral Drugs Consumption Value by Application (2018-2029)
6.3 Global Oncolytic Viral Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
7.2 North America Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
7.3 North America Oncolytic Viral Drugs Market Size by Country
7.3.1 North America Oncolytic Viral Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Oncolytic Viral Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Oncolytic Viral Drugs Market Size by Country
8.3.1 Europe Oncolytic Viral Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Oncolytic Viral Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oncolytic Viral Drugs Market Size by Region
9.3.1 Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oncolytic Viral Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
10.2 South America Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
10.3 South America Oncolytic Viral Drugs Market Size by Country
10.3.1 South America Oncolytic Viral Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Oncolytic Viral Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oncolytic Viral Drugs Market Size by Country
11.3.1 Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oncolytic Viral Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Oncolytic Viral Drugs Market Drivers
12.2 Oncolytic Viral Drugs Market Restraints
12.3 Oncolytic Viral Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oncolytic Viral Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oncolytic Viral Drugs
13.3 Oncolytic Viral Drugs Production Process
13.4 Oncolytic Viral Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oncolytic Viral Drugs Typical Distributors
14.3 Oncolytic Viral Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Oncolytic Viral Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncolytic Viral Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Amgen, Inc. Major Business
Table 5. Amgen, Inc. Oncolytic Viral Drugs Product and Services
Table 6. Amgen, Inc. Oncolytic Viral Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amgen, Inc. Recent Developments/Updates
Table 8. Daiichi Sankyo Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Daiichi Sankyo Co., Ltd. Major Business
Table 10. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product and Services
Table 11. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Daiichi Sankyo Co., Ltd. Recent Developments/Updates
Table 13. Rigvir Holding Basic Information, Manufacturing Base and Competitors
Table 14. Rigvir Holding Major Business
Table 15. Rigvir Holding Oncolytic Viral Drugs Product and Services
Table 16. Rigvir Holding Oncolytic Viral Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Rigvir Holding Recent Developments/Updates
Table 18. Shanghai Pharma Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 19. Shanghai Pharma Sunway Biotech Major Business
Table 20. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product and Services
Table 21. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shanghai Pharma Sunway Biotech Recent Developments/Updates
Table 23. Global Oncolytic Viral Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Oncolytic Viral Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Oncolytic Viral Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 26. Market Position of Manufacturers in Oncolytic Viral Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Oncolytic Viral Drugs Production Site of Key Manufacturer
Table 28. Oncolytic Viral Drugs Market: Company Product Type Footprint
Table 29. Oncolytic Viral Drugs Market: Company Product Application Footprint
Table 30. Oncolytic Viral Drugs New Market Entrants and Barriers to Market Entry
Table 31. Oncolytic Viral Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Oncolytic Viral Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Oncolytic Viral Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Oncolytic Viral Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Oncolytic Viral Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Oncolytic Viral Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 37. Global Oncolytic Viral Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 38. Global Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Oncolytic Viral Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Oncolytic Viral Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Oncolytic Viral Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 43. Global Oncolytic Viral Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 44. Global Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Oncolytic Viral Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Oncolytic Viral Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Oncolytic Viral Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Oncolytic Viral Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 50. North America Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Oncolytic Viral Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Oncolytic Viral Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Oncolytic Viral Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Oncolytic Viral Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Oncolytic Viral Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Oncolytic Viral Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Oncolytic Viral Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Oncolytic Viral Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Oncolytic Viral Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Oncolytic Viral Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Oncolytic Viral Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Oncolytic Viral Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Oncolytic Viral Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Oncolytic Viral Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Oncolytic Viral Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Oncolytic Viral Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Oncolytic Viral Drugs Raw Material
Table 91. Key Manufacturers of Oncolytic Viral Drugs Raw Materials
Table 92. Oncolytic Viral Drugs Typical Distributors
Table 93. Oncolytic Viral Drugs Typical Customers
LIST OF FIGURE
s
Figure 1. Oncolytic Viral Drugs Picture
Figure 2. Global Oncolytic Viral Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncolytic Viral Drugs Consumption Value Market Share by Type in 2022
Figure 4. Natural Virus Examples
Figure 5. Genetically Modified Virus Examples
Figure 6. Global Oncolytic Viral Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Oncolytic Viral Drugs Consumption Value Market Share by Application in 2022
Figure 8. Nasopharyngeal Cancer Examples
Figure 9. Melanoma Examples
Figure 10. Glioma Examples
Figure 11. Other Examples
Figure 12. Global Oncolytic Viral Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Oncolytic Viral Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Oncolytic Viral Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Oncolytic Viral Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Oncolytic Viral Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Oncolytic Viral Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Oncolytic Viral Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Oncolytic Viral Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Oncolytic Viral Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Oncolytic Viral Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Oncolytic Viral Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Oncolytic Viral Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Oncolytic Viral Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Oncolytic Viral Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Oncolytic Viral Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Oncolytic Viral Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Oncolytic Viral Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Oncolytic Viral Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Oncolytic Viral Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Oncolytic Viral Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Oncolytic Viral Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Oncolytic Viral Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Oncolytic Viral Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Oncolytic Viral Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Oncolytic Viral Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Oncolytic Viral Drugs Market Drivers
Figure 75. Oncolytic Viral Drugs Market Restraints
Figure 76. Oncolytic Viral Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Oncolytic Viral Drugs in 2022
Figure 79. Manufacturing Process Analysis of Oncolytic Viral Drugs
Figure 80. Oncolytic Viral Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Table 1. Global Oncolytic Viral Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncolytic Viral Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Amgen, Inc. Major Business
Table 5. Amgen, Inc. Oncolytic Viral Drugs Product and Services
Table 6. Amgen, Inc. Oncolytic Viral Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amgen, Inc. Recent Developments/Updates
Table 8. Daiichi Sankyo Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Daiichi Sankyo Co., Ltd. Major Business
Table 10. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product and Services
Table 11. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Daiichi Sankyo Co., Ltd. Recent Developments/Updates
Table 13. Rigvir Holding Basic Information, Manufacturing Base and Competitors
Table 14. Rigvir Holding Major Business
Table 15. Rigvir Holding Oncolytic Viral Drugs Product and Services
Table 16. Rigvir Holding Oncolytic Viral Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Rigvir Holding Recent Developments/Updates
Table 18. Shanghai Pharma Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 19. Shanghai Pharma Sunway Biotech Major Business
Table 20. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product and Services
Table 21. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shanghai Pharma Sunway Biotech Recent Developments/Updates
Table 23. Global Oncolytic Viral Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Oncolytic Viral Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Oncolytic Viral Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 26. Market Position of Manufacturers in Oncolytic Viral Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Oncolytic Viral Drugs Production Site of Key Manufacturer
Table 28. Oncolytic Viral Drugs Market: Company Product Type Footprint
Table 29. Oncolytic Viral Drugs Market: Company Product Application Footprint
Table 30. Oncolytic Viral Drugs New Market Entrants and Barriers to Market Entry
Table 31. Oncolytic Viral Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Oncolytic Viral Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Oncolytic Viral Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Oncolytic Viral Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Oncolytic Viral Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Oncolytic Viral Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 37. Global Oncolytic Viral Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 38. Global Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Oncolytic Viral Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Oncolytic Viral Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Oncolytic Viral Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 43. Global Oncolytic Viral Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 44. Global Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Oncolytic Viral Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Oncolytic Viral Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Oncolytic Viral Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Oncolytic Viral Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 50. North America Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Oncolytic Viral Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Oncolytic Viral Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Oncolytic Viral Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Oncolytic Viral Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Oncolytic Viral Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Oncolytic Viral Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Oncolytic Viral Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Oncolytic Viral Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Oncolytic Viral Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Oncolytic Viral Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Oncolytic Viral Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Oncolytic Viral Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Oncolytic Viral Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Oncolytic Viral Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Oncolytic Viral Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Oncolytic Viral Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Oncolytic Viral Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Oncolytic Viral Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Oncolytic Viral Drugs Raw Material
Table 91. Key Manufacturers of Oncolytic Viral Drugs Raw Materials
Table 92. Oncolytic Viral Drugs Typical Distributors
Table 93. Oncolytic Viral Drugs Typical Customers
LIST OF FIGURE
s
Figure 1. Oncolytic Viral Drugs Picture
Figure 2. Global Oncolytic Viral Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncolytic Viral Drugs Consumption Value Market Share by Type in 2022
Figure 4. Natural Virus Examples
Figure 5. Genetically Modified Virus Examples
Figure 6. Global Oncolytic Viral Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Oncolytic Viral Drugs Consumption Value Market Share by Application in 2022
Figure 8. Nasopharyngeal Cancer Examples
Figure 9. Melanoma Examples
Figure 10. Glioma Examples
Figure 11. Other Examples
Figure 12. Global Oncolytic Viral Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Oncolytic Viral Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Oncolytic Viral Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Oncolytic Viral Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Oncolytic Viral Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Oncolytic Viral Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Oncolytic Viral Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Oncolytic Viral Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Oncolytic Viral Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Oncolytic Viral Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Oncolytic Viral Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Oncolytic Viral Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Oncolytic Viral Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Oncolytic Viral Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Oncolytic Viral Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Oncolytic Viral Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Oncolytic Viral Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Oncolytic Viral Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Oncolytic Viral Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Oncolytic Viral Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Oncolytic Viral Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Oncolytic Viral Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Oncolytic Viral Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Oncolytic Viral Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Oncolytic Viral Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Oncolytic Viral Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Oncolytic Viral Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Oncolytic Viral Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Oncolytic Viral Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Oncolytic Viral Drugs Market Drivers
Figure 75. Oncolytic Viral Drugs Market Restraints
Figure 76. Oncolytic Viral Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Oncolytic Viral Drugs in 2022
Figure 79. Manufacturing Process Analysis of Oncolytic Viral Drugs
Figure 80. Oncolytic Viral Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
